Browse by author
Lookup NU author(s): Professor Nicola PaveseORCiD
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
© 2016 International Parkinson and Movement Disorder Society Molecular imaging has proven to be a powerful tool for investigation of parkinsonian disorders. One current challenge is to identify biomarkers of early changes that may predict the clinical trajectory of parkinsonian disorders. Exciting new tracer developments hold the potential for in vivo markers of underlying pathology. Herein, we provide an overview of molecular imaging advances and how these approaches help us to understand PD and atypical parkinsonisms. © 2016 International Parkinson and Movement Disorder Society.
Author(s): Strafella AP, Bohnen NI, Perlmutter JS, Eidelberg D, Pavese N, Van Eimeren T, Piccini P, Politis M, Thobois S, Ceravolo R, Higuchi M, Kaasinen V, Masellis M, Peralta MC, Obeso I, Pineda-Pardo JA, Cilia R, Ballanger B, Niethammer M, Stoessl JA
Publication type: Review
Publication status: Published
Journal: Movement Disorders
Year: 2017
Volume: 32
Issue: 2
Pages: 181-192
Print publication date: 01/02/2017
Online publication date: 02/02/2017
Acceptance date: 27/11/2016
ISSN (print): 0885-3185
ISSN (electronic): 1531-8257
Publisher: John Wiley and Sons Inc.
URL: https://doi.org/10.1002/mds.26907
DOI: 10.1002/mds.26907